These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 16351736

  • 21. Structure-Based Understanding of Binding Affinity and Mode of Estrogen Receptor α Agonists and Antagonists.
    Lee S, Barron MG.
    PLoS One; 2017; 12(1):e0169607. PubMed ID: 28061508
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of hydrogen bonds of ecdysteroids in the ligand-receptor interactions using a protein modeling system.
    Harada T, Nakagawa Y, Akamatsu M, Miyagawa H.
    Bioorg Med Chem; 2009 Aug 15; 17(16):5868-73. PubMed ID: 19631551
    [Abstract] [Full Text] [Related]

  • 23. Computer-aided identification of novel protein targets of bisphenol A.
    Montes-Grajales D, Olivero-Verbel J.
    Toxicol Lett; 2013 Oct 09; 222(3):312-20. PubMed ID: 23973438
    [Abstract] [Full Text] [Related]

  • 24. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method.
    van Lipzig MM, ter Laak AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, Meerman JH.
    J Med Chem; 2004 Feb 12; 47(4):1018-30. PubMed ID: 14761204
    [Abstract] [Full Text] [Related]

  • 25. 3D model of amphioxus steroid receptor complexed with estradiol.
    Baker ME, Chang DJ.
    Biochem Biophys Res Commun; 2009 Aug 28; 386(3):516-20. PubMed ID: 19540191
    [Abstract] [Full Text] [Related]

  • 26. Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor.
    Li Y, Suino K, Daugherty J, Xu HE.
    Mol Cell; 2005 Aug 05; 19(3):367-80. PubMed ID: 16061183
    [Abstract] [Full Text] [Related]

  • 27. Is it possible docking and scoring new ligands with few experimental data? Preliminary results on estrogen receptor as a case study.
    Cozzini P, Dottorini T.
    Eur J Med Chem; 2004 Jul 05; 39(7):601-9. PubMed ID: 15236840
    [Abstract] [Full Text] [Related]

  • 28. Predicting Potential Endocrine Disrupting Chemicals Binding to Estrogen Receptor α (ERα) Using a Pipeline Combining Structure-Based and Ligand-Based in Silico Methods.
    Sellami A, Montes M, Lagarde N.
    Int J Mol Sci; 2021 Mar 11; 22(6):. PubMed ID: 33799614
    [Abstract] [Full Text] [Related]

  • 29. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery.
    Laskowski RA, Swindells MB.
    J Chem Inf Model; 2011 Oct 24; 51(10):2778-86. PubMed ID: 21919503
    [Abstract] [Full Text] [Related]

  • 30. Conformational dynamics of the estrogen receptor alpha: molecular dynamics simulations of the influence of binding site structure on protein dynamics.
    Celik L, Lund JD, Schiøtt B.
    Biochemistry; 2007 Feb 20; 46(7):1743-58. PubMed ID: 17249692
    [Abstract] [Full Text] [Related]

  • 31. Insights into ligand selectivity in estrogen receptor isoforms: molecular dynamics simulations and binding free energy calculations.
    Zeng J, Li W, Zhao Y, Liu G, Tang Y, Jiang H.
    J Phys Chem B; 2008 Mar 06; 112(9):2719-26. PubMed ID: 18266357
    [Abstract] [Full Text] [Related]

  • 32. A novel pesticide-induced conformational state of the oestrogen receptor ligand-binding domain, detected by conformation-specific peptide binding.
    Sumbayev VV, Bonefeld-Jørgensen EC, Wind T, Andreasen PA.
    FEBS Lett; 2005 Jan 17; 579(2):541-8. PubMed ID: 15642373
    [Abstract] [Full Text] [Related]

  • 33. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity.
    Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR.
    Science; 2001 Jun 22; 292(5525):2329-33. PubMed ID: 11408620
    [Abstract] [Full Text] [Related]

  • 34. Activation of steroid hormone receptors: Shed light on the in silico evaluation of endocrine disrupting chemicals.
    Chen Q, Tan H, Yu H, Shi W.
    Sci Total Environ; 2018 Aug 01; 631-632():27-39. PubMed ID: 29522903
    [Abstract] [Full Text] [Related]

  • 35. The identification of ligand features essential for PXR activation by pharmacophore modeling.
    Schuster D, Langer T.
    J Chem Inf Model; 2005 Aug 01; 45(2):431-9. PubMed ID: 15807509
    [Abstract] [Full Text] [Related]

  • 36. Molecular basis of the interaction specificity between the human glucocorticoid receptor and its endogenous steroid ligand cortisol.
    von Langen J, Fritzemeier KH, Diekmann S, Hillisch A.
    Chembiochem; 2005 Jun 01; 6(6):1110-8. PubMed ID: 15883974
    [Abstract] [Full Text] [Related]

  • 37. How estrogen-specific proteins discriminate estrogens from androgens: a common steroid binding site architecture.
    Nahoum V, Gangloff A, Shi R, Lin SX.
    FASEB J; 2003 Jul 01; 17(10):1334-6. PubMed ID: 12759331
    [Abstract] [Full Text] [Related]

  • 38. Are all EDC effects mediated via steroid hormone receptors?
    Fisher JS.
    Toxicology; 2004 Dec 01; 205(1-2):33-41. PubMed ID: 15458788
    [Abstract] [Full Text] [Related]

  • 39. Molecular modeling of cardiac glycoside binding by the human sequence monoclonal antibody 1B3.
    Paula S, Monson N, Ball WJ.
    Proteins; 2005 Aug 15; 60(3):382-91. PubMed ID: 15971203
    [Abstract] [Full Text] [Related]

  • 40. Mixed-model QSAR at the human mineralocorticoid receptor: predicting binding mode and affinity of anabolic steroids.
    Peristera O, Spreafico M, Smiesko M, Ernst B, Vedani A.
    Toxicol Lett; 2009 Sep 28; 189(3):219-24. PubMed ID: 19523507
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.